The Latest Breaking News from FDA

With the rapid integration of technology into healthcare, the need for robust cybersecurity measures has become a non-negotiable. Medical devices, which increasingly rely on software and connectivity, bring unprecedented convenience and improved ...

Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling a cheaper, generic version of the drug your doctor prescribed.

The recalled baby teething product was sold in 45 states

There is a "warning of potentially serious or even deadly consequences from consuming the product"

The CISA and FDA have released security warnings about the Contec CMS8000, which is used for patient monitoring.

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depression, the FDA says. Here's what that means.

Three products from Cal Yee Farm’s recall last month are now a ‘Class 1’ level

As I’ve grown older and experienced the vagaries of my ageing memory, I’ve often reflected on the possibility of a miracle cure that would rejuvenate it. As if in answer to my wishful thinking, not one but several reports recently appeared simultaneously in the scientific news, highlighting a trending solution…

The new drug will be many times more expensive than a standard opioid option

Over 35 years after the first study linking Red 3 to thyroid cancer in rats was published, the US is beginning to wean it out of foods and drugs.